News

Dr. Amendola Takes Helm as AAOS President for 2025

Dr. Amendola Takes Helm as AAOS President for 2025

Dr. Annunziato (Ned) Amendola Appointed President of AAOS

The American Academy of Orthopaedic Surgeons (AAOS) proudly announces the appointment of Dr. Annunziato (Ned) Amendola as the new president. Dr. Amendola is a distinguished professor of orthopaedic surgery and the chief of sports medicine at Duke University. His leadership journey begins following the AAOS 2025 Annual Meeting, marking a significant moment in his commitment to advancing the field.

A Vision for the Future of Orthopaedics

In his acceptance speech, Dr. Amendola shared his vision: "It is a great honor to serve as the 93rd president of the AAOS. I am dedicated to providing our members with the crucial tools, resources, and support necessary to deliver exceptional musculoskeletal care to patients. By promoting collaboration within the orthopaedic community, we can drive progress and fortify the future of our profession." His commitment is evident in his past roles and achievements.

Dr. Amendola’s Extensive Experience in Sports Medicine

Dr. Amendola has led Duke's sports medicine program since 2015 and is also the executive director of the James R. Urbaniak, MD, Sports Sciences Institute. His role as the Virginia Flowers Baker Distinguished Professor exemplifies his dedication, as he also serves as the head team physician and chief medical officer for Duke Athletics.

Collaborative Leadership and AAOS Engagement

With almost 30 years of experience, Dr. Amendola's leadership journey within AAOS reflects a profound commitment to the organization and its members. He has played a pivotal role in shaping educational programming and has served in various important capacities:

  • Chair of the 2011 AAOS Annual Meeting Program Committee.
  • Member of the ORS-AAOS Co-Programming Committee.
  • Member-at-large of the AAOS Board of Directors since 2012.
  • Appointed deputy editor of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS).

Advancing Patient Care in Orthopaedics

Beyond AAOS, Dr. Amendola’s career is characterized by his commitment to enhancing patient care through collaboration across major orthopaedic boards and societies:

  • Board member of the Orthopaedic Research and Education Foundation (OREF).
  • Former president of the American Orthopaedic Society for Sports Medicine (AOSSM).
  • Served on the Board of Directors for ISAKOS and AANA.

Innovative Contributions to Sports Medicine

Dr. Amendola is celebrated for his contributions to arthroscopic techniques and biologic repairs crucial for treating ankle and knee injuries. His innovative spirit has led to significant advancements in surgical practices and the development of new technologies in orthopaedics.

A prominent researcher, he has received multiple grants and authored over 300 peer-reviewed publications. His contributions to the field have garnered numerous accolades, including the Excellence in Research Award and the Kappa Delta Ann Doner Vaughn Award.

A Prominent Path in Orthopedic Medicine

Dr. Amendola's early career began in Canada, where he obtained his medical degree and completed his residency at the University of Western Ontario. He holds notable fellowships in sports medicine, foot and ankle surgery, and hand surgery. His vast experience includes directing the sports medicine program at the University of Iowa before joining Duke University.

About the AAOS

The American Academy of Orthopaedic Surgeons is the world's largest medical association of musculoskeletal specialists, boasting over 39,000 members. The AAOS leads the way in advancing musculoskeletal health through education and quality care information, ensuring orthopaedic surgeons are well-equipped to treat patients effectively.

Frequently Asked Questions

Who is Dr. Annunziato (Ned) Amendola?

Dr. Amendola is an esteemed professor and chief of sports medicine at Duke University, recently appointed as president of the AAOS.

What are Dr. Amendola's notable contributions?

He has contributed to educational programming and serves on multiple orthopaedic boards, pushing innovations in patient care and surgical techniques.

What is the AAOS?

The AAOS is a leading organization that unites musculoskeletal specialists to improve patient care through education and advocacy.

What is Dr. Amendola's vision as president of AAOS?

He aims to enhance support for AAOS members and foster collaboration within the orthopaedic community to drive progress.

Where did Dr. Amendola begin his career?

His career started in Canada, where he earned his medical degree and completed his residency at the University of Western Ontario.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 214

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
SDI Presence Marks 30 Years with Top Workplace Honor

Updated Category News Views 148

30 Years of Innovation and Recognition If you've been around the block like I have, you know that anniversaries in the corporate world are more than just cake and confetti. For SDI Presence, hitting their 30th year alongside a ninth consecutive Chicago Tribune Top Workplaces recognition smacks of substance and staying power. These folks aren’t just resting on their...

Continue Reading
Dana Concludes Tender Offers for Senior Notes

Updated Category News Views 124

An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 81

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
GTEC Faces Nasdaq Bid Price Compliance Challenge

Updated Category News Views 127

Greenland Technologies in a Tight Spot Man, stocks can be as unpredictable as a cat on a hot tin roof, and Greenland Technologies Holding Corporation (Nasdaq: GTEC) just got a cold splash of reality from Nasdaq. On November 10, 2026, they were handed a Notification Letter that ain’t exactly a love note. Their shares slipped below the one-buck hurdle, and Nasdaq isn’t...

Continue Reading
BTQ Technologies Calls Investors for Key Quantum Update

Updated Category News Views 107

You know what's stirring the pot over at BTQ Technologies? A shareholder call coming up soon, and boy, it's got 'eye-opening insights' written all over it. We're talkin' Q3 financial results and, likely, a smattering of future plans on the quantum front, folks. Diving into BTQ's Quantum Vision BTQ Technologies Corp. (NASDAQ: BTQ) isn't just another tech firm banging on...

Continue Reading
Terra Kaffe's Big Win with Oprah's Endorsement

Updated Category News Views 98

Terra Kaffe Hits the Jackpot with Oprah Sometimes, destiny has a way of handing out golden tickets, and for Terra Kaffe, receiving a nod from Oprah Winfrey's revered list of Favorite Things for 2026 is nothing short of that. I mean, you can't underestimate the pull Mrs. O has. Her endorsement isn’t just another celebrity pat-on-the-back, it’s a megaphone blaring...

Continue Reading
Enjay Acquires New Method: A Strategic Synergy Unfolds

Updated Category News Views 105

Enjay's Bold Move into New Territory Here's a headline that doesn’t just flutter past like yesterday's news. Enjay Converters Ltd, straight from Cobourg, Ontario, has clinched a deal that looks like it might just shake things up a bit on the food packaging scene. They’ve bagged New Method Packaging LLC, another big player, but this time from the heartland of...

Continue Reading
HNTB Partners with Kansas City Chiefs for New Stadium

Updated Category News Views 103

A New Chapter for the Kansas City Chiefs Are we witnessing the dawn of a new era for the Kansas City Chiefs? Officially naming HNTB as the architect for their upcoming stadium signals a strategic pivot, aimed at not just snagging eyeballs, but embedding Kansas City deeper into the sports architecture hall of fame. Unveiled during the Power Brokers Sports-Anchored...

Continue Reading
Wiz Khalifa Ignites MJBizCon 2026 with Keynote and Music

Updated Category News Views 161

An Icon in Cannabis Culture Hits the Stage When you mix business with pleasure, you get something like what MJBizCon's cooking up this year. Wiz Khalifa, the man with a knack for turning passion into profit, is jumping onto the stage—not just as a performer, but also as a keynote speaker. On December 2, attendees are in for a treat as he steps into a new spotlight at...

Continue Reading

Top 5 Most Recently Viewed Articles

Matinas BioPharma Welcomes New Board Member and Funding Deal

Updated Category News Views 163

Introduction to Recent Developments at Matinas BioPharma Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) is making headlines with its latest announcement about a major agreement involving the acquisition of preferred stock and the appointment of a new board member. This strategic move promises to bolster the company's position as a leading biopharmaceutical entity...

Continue Reading
Forecasting the Future of Intelligent Transportation Systems

Updated Category News Views 218

Understanding the Intelligent Transportation System Market The intelligent transportation system (ITS) market is on track to achieve remarkable growth, with an estimated value of USD 55.36 billion anticipated in the coming years. This growth marks an increase from USD 42.55 billion in recent years, demonstrating a compound annual growth rate (CAGR) of 5.4% as per the...

Continue Reading
Revolutionizing Hospitality: Experience the Future with AI

Updated Category News Views 128

Transforming the Hotel Experience with AI Hotels today have evolved far beyond basic digital solutions like QR codes to access menus. The landscape is shifting, and at the forefront of this change is Product Genius, a platform that harnesses the power of AI to revolutionize guest interactions. With its advanced features, Product Genius provides hotels with a way to...

Continue Reading
Champions Oncology Reaches New Heights with Stock Surge

Updated Category News Views 126

Champions Oncology Stock Experiences Remarkable Growth Champions Oncology, Inc. (NASDAQ: CSBR) has recently reached an impressive milestone in its stock performance, hitting a new 52-week high of $9.94. This surge comes alongside significant advancements in the company’s market capitalization, currently standing at approximately $133 million, with an annual revenue of...

Continue Reading
Investor Alert: Protect Your Rights with iLearningEngines, Inc.

Updated Category News Views 93

Protecting Investor Rights: Insights into iLearningEngines, Inc. iLearningEngines, Inc. (NASDAQ: AILE) is under significant scrutiny due to claims that may impact its investors. The Rosen Law Firm is currently investigating these situations, emphasizing the importance for shareholders to be informed and proactive regarding their rights. Understanding the Allegations There...

Continue Reading